Geus Aart De Sells 25,000 Shares of Synopsys (NASDAQ:SNPS) Stock

Synopsys, Inc. (NASDAQ:SNPSGet Free Report) insider Geus Aart De sold 25,000 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the transaction, the insider owned 120,421 shares in the company, valued at approximately $53,197,180.96. This represents a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Geus Aart De also recently made the following trade(s):

  • On Tuesday, September 1st, Geus Aart De sold 24,641 shares of Synopsys stock. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04.
  • On Friday, August 28th, Geus Aart De sold 25,000 shares of Synopsys stock. The stock was sold at an average price of $445.55, for a total transaction of $11,138,750.00.

Synopsys Stock Performance

Shares of SNPS stock traded up $1.15 during trading on Wednesday, reaching $415.97. The company had a trading volume of 1,268,643 shares, compared to its average volume of 1,994,018. The firm’s 50 day simple moving average is $415.20 and its two-hundred day simple moving average is $439.99. Synopsys, Inc. has a one year low of $366.00 and a one year high of $615.79. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The company has a market capitalization of $79.72 billion, a PE ratio of 73.49, a PEG ratio of 2.41 and a beta of 1.23.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business’s quarterly revenue was up 42.4% compared to the same quarter last year. During the same period in the prior year, the company earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Sell-side analysts forecast that Synopsys, Inc. will post 11 earnings per share for the current year.

Hedge Funds Weigh In On Synopsys

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Foronjy Financial LLC boosted its holdings in shares of Synopsys by 5.2% in the 4th quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock valued at $210,000 after acquiring an additional 22 shares during the last quarter. AGH Wealth Advisors LLC lifted its holdings in shares of Synopsys by 4.4% in the 1st quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company’s stock valued at $226,000 after buying an additional 24 shares during the period. Hardy Reed LLC boosted its stake in shares of Synopsys by 0.8% in the fourth quarter. Hardy Reed LLC now owns 3,309 shares of the semiconductor company’s stock worth $1,554,000 after buying an additional 25 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC raised its position in Synopsys by 16.9% during the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 180 shares of the semiconductor company’s stock valued at $85,000 after acquiring an additional 26 shares in the last quarter. Finally, MCF Advisors LLC grew its stake in shares of Synopsys by 17.8% during the 4th quarter. MCF Advisors LLC now owns 172 shares of the semiconductor company’s stock worth $81,000 after purchasing an additional 26 shares during the period. 85.47% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on SNPS shares. Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 price target on shares of Synopsys in a report on Thursday, August 27th. Robert W. Baird upgraded shares of Synopsys from a “neutral” rating to an “outperform” rating and upped their target price for the company from $558.00 to $560.00 in a research report on Thursday, August 27th. Citigroup lifted their price objective on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Stifel Nicolaus increased their price target on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Finally, UBS Group set a $570.00 price target on shares of Synopsys in a report on Thursday, August 27th. Twelve research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $561.28.

Check Out Our Latest Research Report on Synopsys

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Insider Buying and Selling by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.